Summer Internships - 2024 Office of Clinical Pharmacology Office of Translational Sciences

The internships are designed to be 12 weeks during the period May – September 2024 (starting on or after May 6, 2024, and ending on or before September 27, 2024). Note that start dates must be on a Monday, except for May 27, 2024, due to the federal holiday.

Applications invited to recruit to the following staff for the functioning of Urban Health and Wellness Centres in Malappuram District.

Post : Pharmacist

CORONA Remedies Pvt. Ltd.

Indian Pharmacopoeia Commission (IPC) is an Autonomous Institution of the Ministry of Health and Family Welfare, Govt. of India. IPC is created to set standards of drugs in the country. Its basic function is to update regularly the standards of drugs commonly required for treatment of diseases prevailing in this region. It publishes official documents for improving Quality of Medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP).

Application invited for the posts noted below to National Health Mission (NHM) under District Health & Family Welfare Society, Arogyakeralam, Pathanamthitta on contract basis. Last date of application invited is on 24.01.2024, 5.00 pm at Office of the District Program Manager, Arogyakeralam, First floor, Mampra Heights II, Near Kerala Bank, Pathanamthitta.

Post : Pharmacist

The North-Eastern Hill University Act (24 of 1973) passed by both Houses of Parliament received the assent of the President of India on May 26th, 1973.

The recruitment process for the vacant posts under Rashtriya Nagari Arogya Abhiyaan (NUHM) is to be done on a purely temporary basis on a monthly lump sum basis as shown in the table below. Direct interview for the post of Medical Officer (Walk in interview) dt. will be held on 31/01/2024 and Staff Nurse (Female), Staff Nurse (Male), A.N.M. Pharmacist and Epidemiologist, interested and eligible candidates for the post should apply in the prescribed format to Health Department, 3rd Floor, Namumpa Headquarters, Plot No.1, Sec.

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

As one of the world's leading pharmaceutical companies, Intas is committed to fulfilling the unmet global medical needs through comprehensive, progressive and affordable medical products. To fuel its ever-expanding vision, Intas Pharmaceuticals is looking for elite professionals aiming to take their careers to the next level through the following positions.

Post : Senior Research Associate / Research Scientist - NDDS

ONLINE Applications are invited for the posts mentioned below in State/District Health and Family Welfare Society, National Rural Health Mission

Post : Pharmacist

Rusan Pharma Ltd. is a fully integrated global pharmaceutical company specializing in the treatment of Addiction and Pain Management.  We offer a complete range of products for de-addiction and pain management in countries across the globe including Europe, UK, Russia, CIS, South Africa, Mauritius, Nepal and Myanmar.

Post : Medical Writer

Wockhardt Ltd. is a global pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients.

Jr. Executive / Executive Production
Experience : 2 to 5 years in Production Upstream / Downstream from Biosimilar Industry.
Qualification : M.Sc.(Biotech / Microbiology), BE / B.Technology (Biotech/Chemical)

Otsuka Pharmaceutical India Private Limited is a Joint Venture between Otsuka Pharmaceutical Factory, Inc., Japan and Mitsui & Co. Ltd., Japan, for Infusion Business in India and Emerging Markets. We primarily manufacture & market products across multiple markets and therapeutic segments. Being a leader in intravenous nutrition products, we are committed to being the best partner of patients and healthcare professionals in the field of clinical nutrition.

Legacy of Alembic Pharmaceuticals Limited (APL) dates back to over 100 years. Established in 1907 with an objective to develop and revolutionize the Pharmaceutical and Drug industry in the Indian subcontinent, Alembic Pharmaceuticals Limited today is one of the leading pharmaceutical companies in India.

Post : Area Manager - for Generic Division

Hester Biosciences Limited is one of India’s leading animal healthcare companies and is the second largest poultry vaccine manufacturer in the country. Founded by Mr. Rajiv Gandhi, Hester began its journey in 1987. Over the years, it has transformed from a small proprietary trading business into Asia’s largest one-stop animal biological manufacturing facility. We now have a strategic presence in over 30 countries, while focusing on key market needs in India, Nepal and Tanzania.

Rusan Pharma Ltd. is a fully integrated global pharmaceutical company specializing in the treatment of Addiction and Pain Management.  We offer a complete range of products for de-addiction and pain management in countries across the globe including Europe, UK, Russia, CIS, South Africa, Mauritius, Nepal and Myanmar.

WALK IN DRIVE

No of posts : 03

Maithri Drugs is one of Indias fast-growing pharmaceutical companies. Maithris strategic focus is on active pharma ingredients (APIs). The company is widely recognized for its excellent research and development and aggressive growth strategies. Our 39 US DMFs and 14 CEPs in a short span attest to our R&D excellence.

R&D Department

Sun Pharm and Taro Pharmaceutical Industries Ltd.  announced that they have entered into a definitive merger agreement in which Sun Pharma, Taro’s controlling shareholder, has agreed to acquire all of the outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its affiliates for USD 43.00 per share in cash without interest.

Sun Pharma and Bayer announced that both companies have signed an agreement to market and distribute a second brand of Finerenone in India. Finerenone, a patented medicine is indicated to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease associated with type 2 diabetes mellitus.